67th American Diabetes Association Annual Scientific Session Updates
This supplement will strive to educate physicians and diabetes educators as to the importance of avoiding hyperglycemia in hospitalized patients as well as the role of postprandial hyperglycemia in increasing the risk of cardiovascular disease.
This Continuing Medical Education supplement offers key clinical insights to health care providers on the many issues surrounding the initiation of insulin therapy.
The Why and Wherefore of Glucose Control in Type 2 Diabetes Mellitus
Insulin was first used to treat diabetes mellitus (DM) in 1922. Most of the diagnosed cases of DM then were symptomatic and, thus, type 1 DM. Blood glucose testing generally was not done unless the patient developed symptoms; as a result, most cases of type 2 DM went undiagnosed. As insulin therapy rapidly became available, deaths from diabetic ketoacidosis (DKA) plummeted. In the mid-20th century it became apparent that, although insulin therapy conferred an immediate survival benefit, it allowed the later development of vascular complications. By the mid-1940s, most deaths from diabetes were cardiorenal in nature and few were ascribed to DKA.
This supplement is a valuable reference for all practitioners. The poster and presentation summaries present new insights into the wide world of insulin and incretin mimetic therapy. The content is an excellent overview of where we are in insulin therapy today.
Publication of this special issue of Insulin is timely, bringing together like-minded clinicians who present the rationale for use of intensive insulin therapy. Topics include the underlying pathophysiology, practical implementation of treatment, and outcomes from a large cohort of cardiac surgical cases.
